524400
ISHITADR
Start SIP
Invest Now
Start SIP in ISHITADR
Performance
- Low
- ₹75
- High
- ₹75
- 52 Week Low
- ₹62
- 52 Week High
- ₹100
- Open Price₹75
- Previous Close₹75
- Volume1
Investment Returns
- Over 1 Month + 6.7%
- Over 3 Month -1.67%
- Over 6 Month -6.63%
- Over 1 Year -14.01%
Smart Investing Starts Here Start SIP with Ishita Drugs & Industries for Steady Growth!
Ishita Drugs & Industries Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 23
- PEG Ratio
- 0.7
- Market Cap Cr
- 22
- P/B Ratio
- Average True Range
- 2.08
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.29
- RSI
- 56.59
- MFI
- 62.76
Ishita Drugs & Industries Financials
Ishita Drugs & Industries Technicals
EMA & SMA
Current Price
₹74.69
0
(0%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹72.54
- 50 Day
- ₹73.38
- 100 Day
- ₹74.77
- 200 Day
- ₹76.16
Resistance and Support
74.69
- R3 74.69
- R2 74.69
- R1 74.69
- S1 74.69
- S2 74.69
- S3 74.69
Ishita Drugs & Industries Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-06-13 | Others | Inter-alia, to consider 1. To Update regarding the current business operations of the Company. 2. Other business matters. |
| 2025-05-30 | Audited Results | |
| 2025-02-13 | Quarterly Results |
Ishita Drugs & Industries F&O
About Ishita Drugs & Industries
- NSE Symbol
- ISHITADR
- BSE Symbol
- 524400
- Managing Director
- Mr. Jagdish Agrawal
- ISIN
- INE806D01016
Similar Stocks to Ishita Drugs & Industries
Ishita Drugs & Industries FAQs
Ishita Drugs & Industries share price is ₹74 As on 12 December, 2025 | 11:36
The Market Cap of Ishita Drugs & Industries is ₹22.3 Cr As on 12 December, 2025 | 11:36
The P/E ratio of Ishita Drugs & Industries is 23 As on 12 December, 2025 | 11:36
The PB ratio of Ishita Drugs & Industries is 2.1 As on 12 December, 2025 | 11:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.